Skip to content
OpenCapital
Get started

Solid Biosciences Inc. SLDB Market capitalization

Market capitalization at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$2.28B-63.1%
Biogen logo
BiogenBIIB
$26.91B+34.3%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.22B+19.9%
Insmed logo
InsmedINSM
$35.25B+155%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$2.99B+153%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.28B+351%

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Enterprise value$634.23M+244%
P/S112.5×-10.3×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Computed from the period-end share price: $708.42M.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s market capitalization?
Solid Biosciences Inc. (SLDB) reported market capitalization of $708.42M in Q1 2026.
How has Solid Biosciences Inc.'s market capitalization changed year-over-year?
Solid Biosciences Inc.'s market capitalization increased by 147.1% year-over-year, from $286.72M to $708.42M.
What is the long-term trend for Solid Biosciences Inc.'s market capitalization?
Over 5 years (2020 to 2025), Solid Biosciences Inc.'s market capitalization has grown at a -12.1% compound annual growth rate (CAGR), from $836.04M to $439.41M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.